The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwNHL 2017 | Describing clonal evolution in lymphoma
Michael Pfreundschuh, MD from the Saarland University, Homburg, Germany is joined by Ryan Morin, PhD from the BC Cancer Agency, Vancouver, Canada, Reiner Siebert, MD from the Institute of Human Genetics, University of Kiel, Kiel, Germany and Robert Kridel, MD, MPH, PhD from the University of Toronto, Toronto, Canada to discuss clonal evolution in lymphoma. Acting as chair, Dr Pfreundschuh leads the panel to review the session’s highlights from the 2017 International Workshop on Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada, focusing on methods of understanding clonal evolution better. The take-home message from this discussion is that it may be possible to not only describe clonal evolution, but to understand the origin and cause of the initial transformation in patients.
